OSPOLOT sulthiame 200 mg tablet bottle Australie - anglais - Department of Health (Therapeutic Goods Administration)

ospolot sulthiame 200 mg tablet bottle

phebra pty ltd - sulthiame, quantity: 200 mg - tablet, film coated - excipient ingredients: purified talc; macrogol 4000; maize starch; lactose monohydrate; titanium dioxide; gelatin; hypromellose; colloidal anhydrous silica; magnesium stearate - indications as at 01 january 1991 : behavioural disorders associated with epilepsy; hyperkinetic behaviour; temporal lobe epilepsy; myoclonic seizures; grand mal attacks; jacksonian seizures.

OSPOLOT sulthiame 50 mg tablet bottle Australie - anglais - Department of Health (Therapeutic Goods Administration)

ospolot sulthiame 50 mg tablet bottle

phebra pty ltd - sulthiame, quantity: 50 mg - tablet, film coated - excipient ingredients: hypromellose; titanium dioxide; macrogol 4000; purified talc; gelatin; lactose monohydrate; magnesium stearate; maize starch; colloidal anhydrous silica - indications as at 01 january 1991 : behavioural disorders associated with epilepsy; hyperkinetic behaviour; temporal lobe epilepsy; myoclonic seizures; grand mal attacks; jacksonian seizures.

OSPOLOT Israël - anglais - Ministry of Health

ospolot

megapharm ltd - sulthiame - film coated tablets - sulthiame 200 mg - sultiame - sultiame - treatment of epilepsy in adults and in treatment of the so called focal benign epilepsy of children, when other medication was not adequate.